Office Locations:

3210 Merryfield Row
San Diego, CA 92121
Phone: 858-242-1504

Get all office locations for this firm with a National Database subscription or Silicon Valley Database subscription.


  • Seed



  • Life Sciences & Healthcare
  • Medical Device



    JLABS is part of Johnson & Johnson's external R&D engine and provides a capital-efficient, resource-rich environment where emerging companies can transform the scientific discoveries of today into the breakthrough healthcare products of tomorrow. The JLABS network encompasses a 40,000 square foot flagship facility in San Diego at Janssen's West Coast Research Center, dedicated space within Lab Central in Boston and QB3@953 in San Francisco, as well as a 30,000 square foot stand-alone facility in South San Francisco (opening 2015). The facilities feature core research labs hosting specialized capital equipment, shared administrative areas and individual bench, wet lab and office modules on a short term basis. Companies pay only for the space they need, with an option to quickly expand when they have the resources to do so. An operations team allows our companies to focus on the science and our business team provides access to education, experts and funding partners. JLABS is a no strings attached model and the agreement for space does not grant Janssen any stake in the companies, nor will the companies have a guaranteed future affiliation with Janssen. JLABS services and amenities vary depending on location. JLABS is part of Janssen Research & Development, one of the Janssen Pharmaceutical Companies of Johnson & Johnson. Dr. Paul Janssen was a world renowned Belgian physician and scientist. With 50,000 francs (less than US $2,000) from his father, Dr. Janssen founded a research laboratory and then went on to found Janssen Pharmaceutical, a company that discovered 80 new medicines. Paul Janssen's story embodies much of what we hope to achieve with JLABS. In that same entrepreneurial spirit, JLABS is the home for high-potential companies looking to transform healthcare with novel discoveries and limited upfront investment.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    Alan Koder Director
    Chelsea Hewitt Head of Marketing
    Kara Bortone PhD Head of Company Sourcing
    Madelaine Holden Marketing and Events Manager
    Melinda Richter Head of JLABS


    Portfolio companies include:

      Amplyx Pharmaceuticals
        web link

      Arcturus Therapeutics
        web link


        web link

      Everist Genomics

      Glycosensors & Diagnostics

      Hera Therapeutics

      Misfolding Diagnostics




    Recent News: